Viatris, Inc. News
Biogen Beats Third-Quarter Earnings, Cuts Guidance
Drugmaker Biogen's third-quarter results feel the effect of generic versions of its multiple sclerosis treatment.
Mylan Will Buy Aspen Pharmacare's Thrombosis Business
Mylan will acquire drugmaker Aspen Pharmacare's European thrombosis business for $757 million.
Gold, Moderna, Qualtrics, Coronavirus: 5 Things You Must Know
Gold surges to an all-time high amid worsening U.S.-China tensions; Wall Street prepares for a week heavy on tech earnings; Moderna secures an additional $472 million to develop a coronavirus vaccine.
Biogen Stock Off After Barclays Downgrade on Patent Ruling
Biogen is downgraded to equal weight by Barclays, which cited an adverse MS-drug patent ruling.
Biogen Loses Court Decision to Mylan Over Multiple Sclerosis Drug
A U.S. District Court judge rules that Mylan proved claims for Biogen’s patent for Tecfidera are invalid for 'lack of written description.'
Breaking News
Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests
Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.
Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat
"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.
New Tesla Product Is a Wish for Fans Hit by Inflation
The manufacturer of premium and high-end electric vehicles became the most profitable American carmaker in the first quarter of 2022.
Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots
"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.